Experience

Davis Polk advised Technip S.A. on the closing of its combination with FMC Technologies, Inc. The transaction to form TechnipFMC plc, the new U.K. combined entity, was implemented through a…

Davis Polk advised Sumitomo Mitsui Banking Corporation in connection with a global medium-term note program update and a benchmark takedown, which consisted of $750 million aggregate…

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. on its SEC-registered takedown offering of senior TLAC notes, which consisted of $750 million aggregate principal amount of 2.846%…

Davis Polk advised the sole global coordinator, sole bookrunner and sole lead manager on a Regulation S only offering of $95 million aggregate principal amount of 7.5% additional senior…

Davis Polk advised the initial purchasers of the inaugural U.S. dollar issuance of senior non-preferred notes by Société Générale. Under its U.S. medium-term note program, Société Générale…

Davis Polk advised the joint book-running managers in connection with a $138 million SEC-registered offering of 4,450,500 shares of common stock of Loxo Oncology, Inc. The common stock is…

Davis Polk advised Roche Holdings, Inc. in connection with a cash tender offer for up to $250 million aggregate principal amount of its 7.00% notes due 2039. Headquartered in Basel,…

Davis Polk advised the joint book-running managers in connection with BPCE’s Section 3(a)(2) offering of $1.25 billion 2.750% notes due 2021 and $600 million 3.375% notes due 2026 under…

Davis Polk advised the joint lead managers and joint bookrunners on a Rule 144A/Regulation S offering of $550 million aggregate principal amount of 4.95% senior notes due 2026 by Listrindo…

Davis Polk is advising Strategic Growth Bancorp Incorporated on its merger with Sunflower Financial, Inc. The transaction will involve a merger of the holding companies and a merger of…